Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      nuBioAge's Clinical Longevity Summit Gathers World-Leading Physicians in West Palm Beach to Deliver the First Comprehensive Roadmap for Post-COVID Treatment

      (PRNewsfoto/NUBIOAGE LLC)

      News provided by

      NUBIOAGE LLC

      Sep 18, 2025, 10:05 ET

      Share this article

      Share this article


      WEST PALM BEACH, Fla., Sept. 18, 2025 /PRNewswire/ -- On September 12–13, 2025, the Hilton West Palm Beach hosted the Clinical Longevity Summit (CLS), a two-day event dedicated to exploring the lasting impacts of COVID-19 on human health and the future of longevity medicine. Presented by nuBioAge, the summit gathered top internationally-recognized clinicians, researchers, and innovators to advance post-COVID care through a systems biology lens.

      Dr. Robin Rose at the Clinical Longevity Summit in West Palm Beach
              Photos by: Juan Medina and Nick Echevarria in West Palm Beach, Florida
      Dr. Robin Rose at the Clinical Longevity Summit in West Palm Beach Photos by: Juan Medina and Nick Echevarria in West Palm Beach, Florida
      nuBioAge Scientific Team "Beyond Recovery" Panel 
              Photos by: Juan Medina and Nick Echevarria
      nuBioAge Scientific Team "Beyond Recovery" Panel Photos by: Juan Medina and Nick Echevarria
      Leonard Pastrana, PharmD and Co-Founder of nuBioAge at the Clinical Longevity Summit
              Dr. Robin Rose at the Clinical Longevity Summit in West Palm Beach, FL
              Photos by: Juan Medina and Nick Echevarria
      Leonard Pastrana, PharmD and Co-Founder of nuBioAge at the Clinical Longevity Summit Dr. Robin Rose at the Clinical Longevity Summit in West Palm Beach, FL Photos by: Juan Medina and Nick Echevarria

      This year's theme, "Building Resilience in a Post-COVID World," brought together experts in pharmacology, cardiology, chemistry, neurology, gastroenterology, and integrative medicine to discuss the impact and precise treatment plans to restore psychological, metabolic, and mitochondrial balance in suffering patients. 

      Leading COVID researcher and internationally sought-after practitioner, Dr. Robin Rose, discussed how COVID reshaped biomarkers, inflammation, and long-term disease risk, while also addressing spike protein persistence and its role in ongoing symptoms. She brought special guest researcher and chemist, Dr. Simone Cristoni, from ISB: Ion Source and BioTechnology R&D Labs, to introduce breakthrough diagnostics capable of differentiating between vaccine-derived and wild-type spike proteins, paving the way for personalized treatment.

      Internationally recognized speaker and practitioner in orthopedics, anti-aging, and regenerative medicine, Dr. Elizabeth Yurth emphasized mitochondrial collapse as the root cause of multi-organ dysfunction and how it can be treated through personalized peptide and mitochondrial therapies and strategies.

      Triple-board-certified pediatric, integrative medicine, and regenerative medicine specialist, Dr. Cynthia Keller, led a two-part deep dive into post-COVID gut collapse and immune breakdown, offering practical peptide and compound protocols to restore resilience in both adolescent and adult patients. Hormone optimization and regenerative medicine expert, Dr. Suzanne Feree, engaged the crowd in a nervous system-regulating moment of gratitude just before discussing the impact of COVID on autonomic dysregulation, and how specific combinations in IV and peptide therapy can restore balance to our nervous system during recovery.

      Preventive cardiologist and triple-board certified physician, Dr. Abid Husain, examined cardiovascular syndromes such as myocarditis and postural orthostatic tachycardia syndrome (POTS), connecting endothelial damage and mitochondrial dysfunction with new therapeutic approaches. And finally, Leonard Pastrana, PharmD and Co-founder of nuBioAge, discussed exercise performance and how strengthening your mitochondria through testing, peptide therapy, and respiratory training can take patients beyond recovery from post-COVID respiratory dysfunction.

      "This summit is about more than recovery. It's about reimagining how we practice medicine in a post-COVID era," said Leonard Pastrana, PharmD, Co-Founder of nuBioAge. "We are building a new standard of care, one where resilience and longevity are at the core of medicine, and most importantly, we're educating and growing a community that can withstand the future of how we practice longevity medicine."

      The summit concluded with the Beyond Recovery panel and Q&A with the nuBioAge Scientific Team, where they explored how these interconnected systems–gut, mitochondria, immune, cardiovascular, and neurological health–impact baseline recovery and the real-world strategies these experts use to build whole-body resilience in post-COVID patients.

      In addition to the all-star line-up of post-COVID experts, the summit showcased exhibitors in respiratory analysis, PNOĒ; compounding pharmacology, Progress Pharmacy; biomarker testing and health analysis, nuHx; and clinical performance optimization ketones, KenetikPro. nuBioAge also showcased a new exclusive peptide-enhancing partner supplement, Vedicinals9, designed to support immune resilience and cellular energy in post-COVID patients.

      "We have so many patients suffering from post-COVID illnesses," said attendee Wandy Schlaug, NP from Crestwood, Kentucky. "With no protocols out there for post-COVID treatment, this conference offered exactly that: an answer to personalized, science-backed treatment I can take back to my practice and my patients." 

      Attendee Marcos de Andrade, MD, said, "...this has been a phenomenal experience. This conference has taught me new ways and strategies for approaching long-COVID treatment, while offering deeper learning into the science of recovery. "

      In closing the summit, nuBioAge announced its next big event, CALM: the Clinical Application of Longevity Medicine, which will return February 27–28, 2026, at the Omni in Fort Lauderdale, Florida, continuing its mission to educate, connect, and empower practitioners in the next era of longevity medicine. For more information on this event, visit wearecalm.life

      If you're interested in learning more about nuBioAge, their peptide-enhancing supplements, longevity and peptide certification courses, the Scientific Team, or their upcoming event CALM, visit nubioage.com. 

      About nuBioAge

      nuBioAge is a longevity science and wellness education network serving medical practitioners and allied health professionals focused on delivering patient-centric, evidence-based longevity medicine. With its comprehensive ecosystem of resources, nuBioAge empowers practitioners to leverage advanced pharmacy networks, state-of-the-art assessments and data, and leading longevity research, education, and clinical implementation.

      Physician-focused, science-backed, and dedicated to advancing transparent practices, nuBioAge is the go-to hub for practitioners committed to delivering clinical longevity medicine for improved healthspan and lifespan outcomes. For more information on how nuBioAge is redefining the future of longevity science, visit www.nubioage.com

      Press Contact:
      Kelli Binnings
      Chief Brand Officer
      [email protected]

      Leonard Pastrana, PharmD
      Co-founder, CEO
      [email protected]

      SOURCE NUBIOAGE LLC

      Modal title

      Also from this source

      As Longevity Medicine Moves Toward Consumers, CALM 2027 Puts Practitioners at the Center

      As Longevity Medicine Moves Toward Consumers, CALM 2027 Puts Practitioners at the Center

      As longevity medicine grows, so does the number of therapies, technologies, diagnostics, and ideas competing for a practitioner's attention. The...

      More Releases From This Source

      Explore

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Education

      Education

      Computer & Electronics

      Computer & Electronics

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.